Avacta Therapeutics
  • About
  • Our Science
  • Pipeline
  • News
  • Investors
  • Careers
  • Contact
  • About
    • About Avacta
    • Leadership
    • Scientific Resources
    • Intellectual Property
  • Our Science
    • Our Science
    • 1st Gen
    • 2nd Gen
    • 3rd Gen
    • Partners
    • Clinical trials
  • Pipeline
  • News
  • Investors
    • Investors
    • Key info
    • Corporate Governance
    • Resources
    • Share price
    • RNS News
    • Events
    • Research
  • Careers
    • Job vacancies
    • Benefits of working at Avacta
  • Contact
  • About
    • About Avacta
    • Leadership
    • Scientific Resources
    • Intellectual Property
  • Our Science
    • Our Science
    • 1st Gen
    • 2nd Gen
    • 3rd Gen
    • Partners
    • Clinical trials
  • Pipeline
  • News
  • Investors
    • Investors
    • Key info
    • Corporate Governance
    • Resources
    • Share price
    • RNS News
    • Events
    • Research
  • Careers
    • Job vacancies
    • Benefits of working at Avacta
  • Contact
Home Investors Results Presentations

Results Presentations

  • Interim Results for the Period Ended 30 June 2022
  • Preliminary Results for the year ending 31 December 2021 – Presentation slides
  • Preliminary Results for the year ending 31 December 2021
  • Interim Results for the 6 Months Period Ending 30th June 2021 – Presentation slides
  • Interim Results for the Period Ended 30 June 2021 and Business Update
  • Preliminary Results for the 12 Months Period Ending 31st December 2020
  • Preliminary Results for the year ending 31 December 2020 – Webinar presentation
  • Preliminary Results for the 12 Months Period Ending 31st December 2020 – Presentation slides
  • Interim Results for the 6 Month Period Ending 30th June 2020
  • Preliminary Results for the 12 Months Period Ending 31st December 2020
  • Interim Results for the 6 Months Period Ending 30th June 2020
  • Prelim Results up to Dec 31st 2019 – Business Update and Outlook Presentation
  • Preliminary Results for the 17-month period ending 31 December 2019
Avacta Therapeutics
  • Diagnostics
  • Terms of Use
  • Terms & Conditions
  • Privacy Policy
  • Intellectual Property
  • Corporate Responsibility
  • Contact Us

Avacta Group plc

Scale Space,  White City
Imperial College Campus
58 Wood Lane
London
W12 7RZ

+44 (0)20 3871 9700

Investor Enquiries

ICR Consilium
85 Gresham Street
London
EC2V 7NQ

 

Email

Twitter | Linkedin

©2025 Avacta Therapeutics. Registered company no. 06605196.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok